The use of fibrinolytic therapy for parapneumonic effusion in pregnancy: a case report and a review

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The use of intrapleural fibrinolytics for complicated parapneumonic effusion has been shown to be an effective and safe alternative to surgery. However, there is limited evidence about its use during pregnancy. We present a case and a review of the literature of pregnant women who had successful treatment of their complicated parapneumonic effusion with intrapleural fibrinolytics. To our knowledge this is the first review of cases of pregnant women with parapneumonic effusion managed with intrapleural fibrinolytic.

Cite

CITATION STYLE

APA

Nasralla, A., Laing, B., & Turner, S. R. (2021, December 1). The use of fibrinolytic therapy for parapneumonic effusion in pregnancy: a case report and a review. Journal of Cardiothoracic Surgery. BioMed Central Ltd. https://doi.org/10.1186/s13019-021-01619-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free